Evidence map›Paper›PMID 36052170›Full record

ArticleFrontiers in molecular biosciences2022

Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer.

Ti-Wei Miao, De-Qing Yang, Li-Juan Gao, Jie Yin, Qi Zhu, Jie Liu, Yan-Qiu He, Xin Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. RedoxOncoimmunology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Ti-Wei MiaoDepartment of Integrated Traditional Chinese and Western Medicine, Zigong First People's Hospital, Zigong, China.
De-Qing YangDepartment of Pharmacy, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Li-Juan GaoDivision of Pulmonary Diseases, Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China.
Jie YinSchool of Automation and Information Engineering, Sichuan University of Science and Engineering, Zigong, China.
Qi ZhuDepartment of Integrated Traditional Chinese and Western Medicine, Zigong First People's Hospital, Zigong, China.
Jie LiuDepartment of Integrated Traditional Chinese and Western Medicine, Zigong First People's Hospital, Zigong, China.
Yan-Qiu HeDepartment of Integrated Traditional Chinese and Western Medicine, West China Hospital of Sichuan University, Chengdu, China.
Xin ChenDepartment of Integrated Traditional Chinese and Western Medicine, Zigong First People's Hospital, Zigong, China.
Zigong First People's Hospital · CNSichuan University · CNKunming Medical University · CNSichuan University of Science and Engineering · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer prognosisgene signatureimmune infiltrationNSCLCredox homeostasis

Identifiers

PMID36052170
PMCPMC9425056
OpenAlexW4292178977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.